EBR Systems (ASX:EBR)
ASX announcement history & article coverage
Transparent by design.
Announcments by EBR Systems (ASX:EBR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Amended Appointment of Chief Medical Officer
Application for quotation of securities - EBR
Appointment of Chief Medical Officer
Q3 2026 Commercial Update
EBR reports weaker Q3 WiSE volumes as commercial reset weighs on implants
Completion of FDA Inspection of New Manufacturing Facility
FDA completes inspection of EBR’s new WiSE manufacturing facility with two observations
Upcoming Australian Investor Conferences
Substantial Holding Notification
CMS Finalises Increased Inpatient Reimbursement for WiSE
CMS finalises higher Medicare reimbursement for EBR's WiSE cardiac pacing system
EBR FDA Plan for Addressing Echo-induced Pacing Risks
EBR to update WiSE System labelling for echo-induced pacing risks after FDA discussions
FDA Initiates Inspection of New Manufacturing Facility
FDA begins pre-approval inspection of EBR Systems manufacturing facility
Investor Roadshow
Update on FDA Review of Cybersecurity Incident
FDA finds no recall or field action warranted after EBR cybersecurity incident
New Manufacturing Facility Achieves ISO Certification
EBR's Santa Clara Facility Achieves ISO Certification and Prepares for FDA Approval
Cleansing Notice
Application for quotation of securities - EBR
Form S-8 Registration Statement
Transition of Chief Commercial Officer
Results of Meeting
Q2 2026 Quarterly Activity Report and Form 10-Q Submission
EBR Systems advances WiSE CRT commercial rollout with major contracts, capital raise, and CMS coverage progress
EBR to Attend Canaccord 46th Annual Growth Conference
Investor Webinar Presentation
Additional Information Regarding Recent Reports
EBR Systems reports isolated serious complications with WiSE system; investigation complete, commercial use continues
Q2 2026 Progress in WiSE Commercial Rollout
EBR Systems advances WiSE commercial rollout with 46 implants and new contracts in Q2 2026
Investor Webinar
Application for quotation of securities - EBR
EBR Responds to Speculation
Launch of WiSE Coupler Accessory for U.S. Commercial Use
EBR Systems launches WiSE Coupler accessory for U.S. commercial use
Notification regarding unquoted securities - EBR
Notification of cessation of securities - EBR